Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain
<p>Abstract</p> <p>Background</p> <p>We previously reported that intrathecal injection of lysophosphatidylcholine (LPC) induced neuropathic pain through activation of the lysophosphatidic acid (LPA)-1 receptor, possibly via conversion to LPA by autotaxin (ATX).</p>...
Main Authors: | Aoki Junken, Chun Jerold, Inoue Makoto, Nagai Jun, Uchida Hitoshi, Ma Lin, Ueda Hiroshi |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2009-11-01
|
Series: | Molecular Pain |
Online Access: | http://www.molecularpain.com/content/5/1/64 |
Similar Items
-
Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain
by: Chun Jerold, et al.
Published: (2008-02-01) -
Autotaxin and lysophosphatidic acid<sub>1 </sub>receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine
by: Aoki Junken, et al.
Published: (2010-11-01) -
Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study.
by: Ken Kuwajima, et al.
Published: (2018-01-01) -
Peripheral mechanisms of neuropathic pain – involvement of lysophosphatidic acid receptor-mediated demyelination
by: Ueda Hiroshi
Published: (2008-04-01) -
2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
by: Keiko Fukasawa, et al.
Published: (2021-08-01)